Advertisement

The Glucagonoma Syndrome

  • S. R. Bloom
  • J. M. Polak
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 106)

Abstract

Although there had been a number of previous reports of non-β cell tumours of the pancreas, some of which might have been producing glucagon, the first report with proper measurement of glucagon levels did not appear until 1966.1 The collection of clinical details from 9 separate glucagonoma patients in 19742 made it possible to delineate the clinical features common to all cases and thus allowed us to report the existence of a “glucagonoma syndrome.” The main features in this were a characteristic rash, necrolytic and migratory erythema, painful glossitis, angular stomatitis, normochromic normocytic anaemia, severe weight loss, diabetes mellitus and the symptoms of a pancreatic tumour. It is of interest that following this description a considerable number of further case reports have appeared reiterating these features.3–11 Presumably such cases were previously overlooked; this demonstrates the benefit of a proper clinical description.

Keywords

Glucagon Level Pancreatic Endocrine Tumour Migratory Erythema Severe Weight Loss Normochromic Normocytic Anaemia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    McGavran MH, Unger RH, Recant L, Polk HC, Kilo C, Levin M: A glucagon-secreting alpha-cell carcinoma of the pancreas. N. Engl. J. Med. 274: 1408–1413, 1966PubMedCrossRefGoogle Scholar
  2. 2.
    Mallinson CN, Bloom SR, Warin AP, Salmon PR, Cox B: A glucagonoma syndrome. Lancet II: 1–4, 1974Google Scholar
  3. 3.
    Scully RE, McNeely BU: Case of glucagonoma in case records of the Massachusetts General Hospital. N. Engl. J. Med. 273: 1117–1123, 1975Google Scholar
  4. 4.
    Soler NG, Dates GD, Malins JM, Cassar J, Bloom SR: Glucagonoma syndrome in a young man. Proc, Roy, Soc, Med. 69: 429–431, 1976Google Scholar
  5. 5.
    Cho KJ, Wilcox CW, Reuter SR: Glucagon-producing islet cell tumor of the pancreas. Am. J. Roentgenol. Radium Ther. Nucl. Med. 129: 159–161, 1977Google Scholar
  6. 6.
    Stevens FM, Flannagan RWJ, Buchanan KD, O’Gorman DJ: The first Irish glucagonoma. Ir. J. Med. Sci. 146: 350, 1977CrossRefGoogle Scholar
  7. 7.
    Kahan RS, Perez-Figaredo RA, Neimanis A: Necrolytic migratory erythema. Arch. Dermatol. 113: 792–797, 1977PubMedCrossRefGoogle Scholar
  8. 8.
    Recant L, Perrino PV, Bhathena SJ, Danforth Jr DN, Lavine RL: Plasma immunoreactive glucagon fractions in four cases of glucagonoma: increased “large glucagon-immunoreactivity,” Diabetologia 12: 319–326, 1976PubMedCrossRefGoogle Scholar
  9. 9.
    Weir GC, Horton ES, Aoki TT, Slovik D, Jaspan J, Rubenstein AH: Secretion by glucagonomas of a possible glucagon precursor. J. Clin. Invest. 59: 325–330, 1977PubMedCrossRefGoogle Scholar
  10. 10.
    Danforth Jr DN, Triche T, Doppman JL, Beazley RM, Perrino PV, Recant L: Elevated plasma proglucagon-like component with a glucagon-secreting tumor. N. Engl. J. Med. 295: 242–245, 1976PubMedCrossRefGoogle Scholar
  11. 11.
    Holst JJ, Pedersen NB: Glucagon-producing tumors of the pancreas. Acta Endocrinol. [Suppl.] 199: 379, 1975Google Scholar
  12. 12.
    Lightman SL, Bloom SR: Cure of insulin-dependent diabetes mellitus by removal of a glucagonoma. Br. Med. J. 1: 367–368, 1974PubMedCrossRefGoogle Scholar
  13. 13.
    Sweet RD: A dermatosis specifically associated with a tumour of pancreatic alpha cells. Br. J. Dermatol, 90: 301–308, 1974PubMedCrossRefGoogle Scholar
  14. 14.
    Pedersen NB, Jonsson L, Holst JJ: Necrolytic migratory erythema and glucagon cell tumor of the pancreas: the glucagonoma syndrome. Acta Dermatol. (Stockholm) 56: 108, 1976Google Scholar
  15. 15.
    Wilkinson DS: Necrolytic migratory erythema with carcinoma of the pancreas. Transactions of St. John’s Hospital Dermatological Society, 59: 244–246, 1973Google Scholar
  16. 16.
    Bloom SR: An enteroglucagon tumour. Gut 13: 520–523, 1972PubMedCrossRefGoogle Scholar
  17. 17.
    Mortimer CH, Carr D, Lind T, Bloom SR, Mallinson CN, Schally AV, Tunbridge WMG, Yeomans L, Coy DH, Kastin A, Besser GM: Growth Hormone release inhibiting hormone: effects on circulating glucagon, insulin and growth hormone in normal, diabetic, acromegalic and hypopituitary patients. Lancet I: 697–701, 1974CrossRefGoogle Scholar
  18. 18.
    Polak JM, Bloom SR, Adrian TE, Heights P, Bryant MG, Pearse AGE: Pancreatic polypeptide in insulinomas, gastrinomas, VIPomas and glucagonomas. Lancet I: 328–330, 1976CrossRefGoogle Scholar
  19. 19.
    Adrian TE, Greenberg GR, Besterman HS, McCloy RF, Chadwick VS, Barnes AJ, Mallinson CN, Baron JH, Alberti KGMM, Bloom SR: PP infusion in man — summary of initial investigations. In: Gut Hormones, ed. SR Bloom, Churchill Livingstone, Edinburgh, 1978, p 265–267Google Scholar
  20. 20.
    Bloom SR, Polak JM, West AM: Somatostatin content of pancreatic endocrine tumours. In: Proceedings of the 1st International Symposium on somatostatin. Metabolism, in pressGoogle Scholar
  21. 21.
    Ingemansson S, Lunderquist A, Holst J: Selective catheterization of the pancreatic vein for radioimmunoassay in glucagon-secreting carcinoma of the pancreas. Radiology 119: 555–556, 1976PubMedGoogle Scholar
  22. 22.
    Allison DJ, Modlin IM, Jenkins WJ: Treatment of carcinoid liver metastases by hepatic-artery embolisation. Lancet II: 1323–1325, 1977CrossRefGoogle Scholar
  23. 23.
    Mallinson CN, Adrian TE, Hanley J, Bryant M, Bloom SR: Metabolic and clinical responses in patients with pancreatic glucagonomas. Ir. J. Med. Sci. 146: 37, 1977Google Scholar
  24. 24.
    Bloom SR, Adrian TE, Barnes AJ, Long RG, Hanley J, Mallinson CN, Rivier JE, Brown MR: New specific long-acting somatostatin analogues in the treatment of pancreatic endocrine tumours, Gut, in pressGoogle Scholar
  25. 25.
    Lomsky R, Langer F, Vortel V: Demonstration of glucagon in islet cell adenomas of the pancreas by immunofluorescent technique. Am. J, Clin. Path. 51: 245–250, 1967Google Scholar

Copyright information

© Plenum Press, New York 1978

Authors and Affiliations

  • S. R. Bloom
    • 1
  • J. M. Polak
    • 1
  1. 1.Departments of Medicine and Histochemistry, The Royal Postgraduate Medical SchoolHammersmith HospitalLondonEngland

Personalised recommendations